This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Other. Active years: 2012.
Company Filing History:
1 out of 834,411 Years Active: 2012
Title: The Innovative Contributions of Sharon Sageman
Introduction
Sharon Sageman is a notable inventor based in New York, NY (US). She has made significant contributions to the field of psychiatry through her innovative research and development of therapeutic methods. Her work focuses on the use of 7-keto DHEA for treating various psychiatric conditions.
Latest Patents
Sharon Sageman holds a patent for her invention titled "7-keto DHEA for psychiatric use." This patent encompasses novel methods for utilizing compositions that include 7-keto DHEA to treat psychiatric conditions. The methods involve administering an effective amount of the composition, either alone or in combination with other psychiatric drugs. These drugs may include analgesic agents, anticonvulsants, anti-anxiety agents, antidepressants, anti-panic agents, antipsychotic agents, bipolar agents, and psychostimulants. The goal is to reduce or ameliorate symptoms associated with psychiatric conditions such as stress disorders, anxiety disorders, and depressive disorders.
Career Highlights
Throughout her career, Sharon Sageman has demonstrated a commitment to advancing psychiatric treatment options. Her innovative approach to using 7-keto DHEA has the potential to provide new avenues for patients suffering from various mental health issues.
Collaborations
Sharon has collaborated with notable individuals in her field, including Richard P. Brown. These collaborations have likely contributed to the development and refinement of her innovative methods.
Conclusion
Sharon Sageman's work exemplifies the impact of innovation in the field of psychiatry. Her patent for 7-keto DHEA represents a significant advancement in treatment options for psychiatric conditions.